RAFAEL PERFECTO VIERA: Open Payments
NPI 1003205519 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 82 payments from 19 companies in 2025. Trend: 2023 $904 · 2024 $1,032 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $282 |
| ABBVIE INC. | 13 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $185 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $180 |
| AstraZeneca Pharmaceuticals LP | 4 | $158 |
| Exact Sciences Corporation | 4 | $96 |
| GlaxoSmithKline, LLC. | 3 | $79 |
| Optinose US, Inc. | 3 | $78 |
| Almatica Pharma LLC | 2 | $54 |
| Lundbeck LLC | 2 | $42 |
Products named: Ozempic, CAPLYTA, Kerendia, FARXIGA, The Cologuard Plus Collection Kit, VRAYLAR, TRELEGY ELLIPTA, Xhance.
Industry payments across FL — which companies pay providers there.
